Vimarsana
Biggest News Aggregation in the World

Page 48 - David Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Ricks Today - Breaking & Trending Today

Pharmaceutical Lobbying Group Challenges Biden Administration Over Medicare Price Negotiations - Vimarsana News

Pharmaceutical Lobbying Group Challenges Biden Administration Over Medicare Price Negotiations

The Pharmaceutical Research and Manufacturers of America (PhRMA), the National Infusion Center Association, and the Global Colon Cancer Association have filed a lawsuit against the Biden administration over Medicare's new powers to reduce drug prices for seniors. The Inflation Reduction Act, which allows Medicare to negotiate drug prices, has faced four lawsuits challenging its provisions. The policy is anticipated to impact the pharmaceutical industry's profits. The lawsuit argues that the Medi

Source: yahoo.com
Eli Lilly Set to Close $2.4B Dice Therapeutics Acquisition to Treat Autoimmune Diseases - Vimarsana News

Eli Lilly Set to Close $2.4B Dice Therapeutics Acquisition to Treat Autoimmune Diseases

Eli Lilly will spend approximately $2.4 billion acquiring Dice Therapeutics to create more drugs to combat autoimmune diseases.

Lilly inks $2.4B cash deal to buy DICE and its immunology pipeline - Vimarsana News

Lilly inks $2.4B cash deal to buy DICE and its immunology pipeline

Eli Lilly, a pharmaceutical firm with headquarters in Indianapolis, has made a risky move in the mergers and acquisitions (M&A) market by announcing its intention to buy South San Francisco-based biotech business DICE Therapeutics.

Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortages - Vimarsana News

Pushback on Price Negotiation; Genetic Testing Lags; More Foreign Help for Shortages

News, features, and commentary about cancer-related issues

The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry - Vimarsana News

The CEO of pharma giant Eli Lilly shares 3 ways AI could transform his industry

Eli Lilly is investing in hundreds of projects focused on AI, machine learning, and automation.

Source: yahoo.com